A phase 1/2 trial of Oxaliplatin(L-OHP) + S-1 in patients with previously untreated advanced colorectal cancer
Ontology highlight
ABSTRACT: Interventions: investigational material(s)
Generic name etc : Oxaliplatin | Tegafur-Gimeracil-Oteracil potassium capsule
INN of investigational material :
Therapeutic category code : 429 Other antitumor agents
Dosage and Administration for Investigational material : Oxaliptatin:Infusion, Tegafur-Gimeracil-Oteracil potassium capsule:Oral
Primary outcome(s): To determine RD,calculate response rate at the RD
Study Design: Open-label,multicenter trial
DISEASE(S): Colorectal Cancer
PROVIDER: 99273 | ecrin-mdr-crc |
REPOSITORIES: ECRIN MDR
ACCESS DATA